文献速递流行病学与生物统计临床试验与 GCP

血液透析整群随机试验关键方法与伦理报告质量亟待提升:一项系统综述

Reporting of key methodological and ethical aspects of cluster trials in hemodialysis require improvement: a systematic review.
PubMed 文献 · Trials · 2020-08-28

该系统综述纳入2000–2019年发表的26项已完成血液透析整群随机试验及5项研究方案,评估其关键方法与伦理问题的报告情况。结果显示,仅48%报告采用整群设计的理由,45%在样本量计算中考虑整群效应,71%在分析中考虑整群效应,42%在两者中均考虑。84%报告获得伦理委员会批准,但患者知情同意过程的报告不完整。

要点

  • 仅48%的血液透析整群随机试验报告了采用整群设计的理由,方法学报告不足。
  • 45%在样本量计算中考虑整群效应,71%在分析中考虑,仅42%在两者中均考虑。
  • 84%报告伦理委员会批准,但知情同意方式及豁免情况报告不完整。

核心结论

  • 未来血液透析整群随机试验在关键方法学与伦理问题的实施和报告方面存在改进空间。

研究设计与样本

  • 系统综述,检索MEDLINE或Embase中2000–2019年发表的英文血液透析整群随机试验。
  • 纳入26项已完成试验和5项研究方案,由两名 reviewers 提取数据,采用描述性统计汇总。

主要发现

  • 研究随机化单位包括血液透析中心(n=17,55%)、透析班次(n=12,39%)、医疗提供者(n=1,3%)和肾脏病单元(n=1,3%)。
  • 试验中位整群数为28,中位整群大小为20例患者。
  • 15项试验(48%)提供了采用整群设计的理由。
  • 样本量计算中考虑整群效应者14项(45%),分析中考虑者22项(71%),两者均考虑者13项(42%)。
  • 26项(84%)报告获得研究伦理委员会批准;22项报告患者知情同意,其中10项(32%)报告参与试验的同意方式,12项(39%)未报告同意获取方式或目的;4项(13%)报告获得知情同意豁免,5项(16%)未提供或不明确。

临床怎么用

  • 开展血液透析整群随机试验时,应明确报告采用整群设计的理由。
  • 样本量计算和数据分析均应考虑整群效应,并完整报告伦理审批及知情同意过程。

局限性

  • 本系统综述采用预先设定的方案但未注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The hemodialysis setting is suitable for trials that use cluster randomization, where intact groups of individuals are randomized. However, cluster randomized trials (CRTs) are complicated in their design, analysis, and reporting and can pose ethical challenges. We reviewed CRTs in the hemodialysis setting with respect to reporting of key methodological and ethical issues. METHODS: We conducted a systematic review of CRTs in the hemodialysis setting, published in English, between 2000 and 2019, and indexed in MEDLINE or Embase. Two reviewers extracted data, and study results were summarized using descriptive statistics. RESULTS: We identified 26 completed CRTs and five study protocols of CRTs. These studies randomized hemodialysis centers (n = 17, 55%), hemodialysis shifts (n = 12, 39%), healthcare providers (n = 1, 3%), and nephrology units (n = 1, 3%). Trials included a median of 28 clusters with a median cluster size of 20 patients. Justification for using a clustered design was provided by 15 trials (48%). Methods that accounted for clustering were used during sample size calculation in 14 (45%), during analyses in 22 (71%), and during both sample size calculation and analyses in 13 trials (42%). Among all CRTs, 26 (84%) reported receiving research ethics committee approval; patient consent was reported in 22 trials: 10 (32%) reported the method of consent for trial participation and 12 (39%) reported no details about how consent was obtained or its purpose. Four trials (13%) reported receiving waivers of consent, and the remaining 5 (16%) provided no or unclear information about the consent process. CONCLUSION: There is an opportunity to improve the conduct and reporting of essential methodological and ethical issues in future CRTs in hemodialysis. REVIEW REGISTRATION: We conducted this systematic review using a pre-specified protocol that was not registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Al-Jaishi AA, Carroll K, Goldstein CE, et al. Reporting of key methodological and ethical aspects of cluster trials in hemodialysis require improvement: a systematic review. Trials. 2020. PMID: 32859245. doi:10.1186/s13063-020-04657-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。